|
Role of p27 in chronic myeloid leukemia and its potential as a therapeutic target
|
5R00CA151670-05
|
$248,246
|
$248,246
|
AGARWAL, ANUPRIYA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Adult Leukemia Research Center
|
4P01CA018029-41
|
$4,225,448
|
$169,018
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The Role of Telomere Shortening in MDS-AML Pathogenesis (resubmission)
|
4R01CA160433-05
|
$336,150
|
$336,150
|
ARMANIOS, MARY
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA082103-18S1
|
$121,856
|
$2,437
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S2
|
$155,534
|
$3,111
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S3
|
$60,000
|
$1,200
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S4
|
$80,100
|
$1,602
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S5
|
$200,000
|
$4,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S6
|
$152,100
|
$3,042
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S7
|
$200,000
|
$4,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S8
|
$749,207
|
$14,984
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
4P30CA082103-18
|
$7,063,742
|
$141,275
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Stopping Tyrosine Kinase Inhibitors in CML Patients (Stop-TKIs)
|
5R01CA184798-03
|
$650,528
|
$650,528
|
ATALLAH, EHAB
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Improved therapeutic approaches for hematological disorder treated with tyrosine
|
4R01CA155091-05
|
$317,475
|
$317,475
|
AZAM, MOHAMMAD
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
A novel hematopoietic stem cell population
|
4F31CA180604-03
|
$48,576
|
$24,288
|
BALCEREK, JOANNA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Regulation of Ceramide-Based Therapeutics in Acute Myeloid Leukemia
|
1K22CA190674-01A1
|
|
$0
|
BARTH, BRIAN
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Regulation of Ceramide-Based Therapeutics in Acute Myeloid Leukemia
|
7K22CA190674-02
|
$161,692
|
$80,846
|
BARTH, BRIAN
|
UNIVERSITY OF NEW HAMPSHIRE
|
|
Cancer Center Support Grant
|
3P30CA042014-27S1
|
$16,667
|
$500
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-27S2
|
$46,556
|
$1,397
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-27S3
|
$33,760
|
$1,013
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-27S4
|
$119,533
|
$3,586
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-27S5
|
$59,998
|
$1,800
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-27S6
|
$113,250
|
$3,398
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-27S7
|
$750,000
|
$22,500
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
5P30CA042014-27
|
$2,274,288
|
$68,229
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Resistance of CML Stem Cells to Imatinib (Gleevec)
|
5R01CA095684-13
|
$275,378
|
$275,378
|
BHATIA, RAVI
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Microenvironmental Regulation of Leukemia Stem Cells
|
5R01CA172447-04
|
$305,025
|
$305,025
|
BHATIA, RAVI
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia
|
4R01CA165469-04
|
$381,420
|
$381,420
|
BONDADA, SUBBARAO
|
UNIVERSITY OF KENTUCKY
|
|
Mechanisms linking RAS signals to disordered hematopoiesis and myeloid neoplasia
|
4R01CA173085-04
|
$328,888
|
$328,888
|
BRAUN, BENJAMIN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Targeting the C/EBPalpha-Gfi-pathway in CML stem cells
|
4R01CA167169-04
|
$321,625
|
$321,625
|
CALABRETTA, BRUNO
|
THOMAS JEFFERSON UNIVERSITY
|
|
Therapeutic Targeting of Leukemia-Microenvironmental Interactions
|
4R01CA166280-04
|
$318,513
|
$318,513
|
CALVI, LAURA
|
UNIVERSITY OF ROCHESTER
|
|
The role of Sin3B in normal and malignant hematopoietic stem cell functions
|
1F30CA203047-01
|
$48,576
|
$48,576
|
CANTOR, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
International Symposium on Juvenile Myelomonocytic Leukemia (JMML)
|
2R13CA132568-10
|
$5,000
|
$5,000
|
CHAN, REBECCA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Impact of aging on the outcomes of a mouse model of chronic myeloid leukemia
|
1UH2CA213385-01
|
$25,705
|
$25,705
|
CHEN, WENYONG
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Fanconi anemia pathway in DNA damage repair
|
4R01CA157448-05
|
$327,850
|
$327,850
|
CHEN, JUNJIE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Genetic Analysis of Myeloproliferative Disease
|
3R01CA076167-13S1
|
$106,561
|
$106,561
|
COWELL, JOHN
|
GEORGIA REGENTS UNIVERSITY
|
|
Genetic Analysis of Myeloproliferative Disease
|
5R01CA076167-13
|
$307,800
|
$307,800
|
COWELL, JOHN
|
GEORGIA REGENTS UNIVERSITY
|
|
Mechanisms of Leukemogenesis in Down Syndrome
|
4R01CA101774-14
|
$303,965
|
$303,965
|
CRISPINO, JOHN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
2P30CA134274-09
|
$2,259,773
|
$90,391
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S1
|
$124,964
|
$4,999
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S2
|
$200,219
|
$8,009
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S3
|
$629,550
|
$25,182
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-41S1
|
$120,000
|
$1,200
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-41S2
|
$123,768
|
$1,238
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-41S3
|
$60,000
|
$600
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-41S4
|
$200,000
|
$2,000
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-41S5
|
$90,000
|
$900
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-41S6
|
$200,000
|
$2,000
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-41S7
|
$499,999
|
$5,000
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-41S8
|
$1,000,006
|
$10,000
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
Total relevant funding to Chronic Myeloproliferative Disorders for this search: $21,275,150
|